IFI-M · UAK Tri-Axis Dominant-Primary Series

Specimen SS-F-M3-02441 // MULTI-AXIS · IFI-M

UAK Tri-Axis Dominant-Primary Series IV-AG

Solanum lycopersicum

Tomato

Tier IVUAK Tri-Axis Dominant-Primary Series

Target Trait

2.38×

fold-change

Umami-dominant tri-axis A+K modulated fold-change

Technical Specifications

SKU

SS-F-M3-02441

Genomic Edits

11

GC Content

45.8%

Construct Length

6,007 bp

Promoter System

Tissue-specific 2A11

Expression System

Agrobacterium-mediated T-DNA

Host Strain

EHA105

Receptor Target

mGluR1 + Polyphenol-astringency axis + CaSR

IFI Score

238

Pathway Edits

  • mGluR1 pathway primary gene cluster for umami (IFI-U) tri-axis component
  • Polyphenol-astringency axis pathway primary gene cluster for astringency (IFI-A) tri-axis component
  • CaSR pathway primary gene cluster for kokumi (IFI-K) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent UAK pathway operation
  • Cross-pathway regulatory circuit for umami-dominant UAK triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: mGluR1, Polyphenol-astringency axis, and CaSR pathways simultaneously engineeredUmami-dominant tri-axis expression strategy (UAK) with cross-pathway flux managementT-DNA binary vector 2A11 for stable genomic integration of multi-axis construct stack

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier IV UAK triple-axis construct for advanced multi-modal sensory architecture combining umami, astringency, and kokumi axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$3999 · Tier IV License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities